News & Publications - Presentations and Posters


European Helicobacter Study Group, 20-22 September 2007, Istanbul, Turkey

Finafloxacin HCl - a novel experimental fluoroquinolone with monotherapeutic potential for Helicobacter pylori eradication
- A.J. Bishop, H. Labischinski, W. Stubbings, A.D. Buss


47th ICAAC, September 2007, Chicago, USA

Friulimicin B, a Cyclic Lipopeptide, Exhibits Potent Efficacy in a Murine Pneumococcal Pneumonia Model
- R. Endermann, A. Vente, H. Labischinski


Friulimicin B Shows Good Efficacy in a Staphylococcal Murine Abscess Infection
- H. Labischinski, M. Glenschek-Sieberth, R. Endermann


Determination of the Predictive PK/PD Parameter for the Efficacy of Friulimicin B in a Murine Staphylococcal Thigh Muscle Infection
- M. Glenschek-Sieberth, S. Pelzer, H. Labischinski, J. Schumacher, R. Endermann


Comparative Analysis of the Bactericidal Activities of Friulimicin B, Daptomycin, Tigecycline, and Vancomycin against Difficult to Treat Isolates of S. aureus and S. pneumoniae
- S. Schubert, A. Dalhoff, S. Pelzer, H. Labischinski


Activity of Friulimicin B Against Glycopeptide and Daptomycin Non-susceptible S. aureus
- P. McGhee, T. Bogdanovich, K. Credito, S. Pelzer, H. Priefert, H. Labischinski, P.C. Appelbaum


Resistance Studies with Friulimicin B and Daptomycin
- W. Stubbings, W. Wu, H. Priefert, S. Pelzer, A. Vente, M. Everett, H. Labischinski


Activity of Friulimicin B and Five Other Antimicrobial Agents against 179 Gram-Positive Obligatory Anaerobic Bacteria
- R. Schaumann, D. Adler, S. Pelzer, H. Labischinski, A. C. Rodloff


Comparative in vitro Activity of the Novel Lipopeptide Friulimicin B with Daptomycin; the Effect of Inoculum, Pulmonary Surfactant and Calcium
- H. Priefert, L. Bylund, S. Pelzer, A. Vente, H. Labischinski


Comparative In Vitro Activities of the Novel Antibacterial Friulimicin B and Other Antibacterial Agents Against Selected Aerobic Gram-positive Bacteria
- M. Kresken, J. Brauers, B. Körber-Irrgang, H. Labischinski, S. Pelzer


Distinct Mode of Action of the Lipopeptide Antibiotic Friulimicin B and the Lipodepsipeptide Daptomycin: A Proteomic Study
- D. Zuehlke, B. Voigt, M. Hecker, S. Jordan, T. Mascher, S. Pelzer, H. Labischinski


Friulimicin B Inhibits Cell Wall Biosynthesis through Complex Formation with Bactoprenol-Phosphate
- T. Schneider, K. Gries, I. Wiedemann, S. Pelzer, H. Labischinski, H. G. Sahl


Addressing the Challenges of Natural Products Drug Discovery - Dr David Appleton

Pan-Asian Network for Neglected Diseases Annual Meeting, June 2007, Shanghai


Leveraging from Mergers and Acquisitions to Sustain Competitive Advantage

Drug Development Asia Summit 2007, June 2007


Automated high throughput separation of crude extracts into fractions for HTS primary screening - Dr David Appleton

IUPAC International Conference on Biodiversity and Natural Products (ICOB-5 & ISCNP-25), July 23-28, 2006, Kyoto, Japan. P-339.